India is amongst a handful of countries in the world that has a broad Novartis presence. This includes four divisions, namely: Pharma International (Commercial operations), Development (Drug development), Biomedical Research and Operations.
Pharma International India
Our commercial operations, Pharma International, are fully aligned to our global strategy of focusing on our innovative portfolios. To ensure that we are truly focused, we have narrowed down on our priority disease areas for India where we can create most value.
We focus on core therapeutic areas with high unmet patient needs and utilize technology platforms that enable cutting-edge innovative therapies:
Cardiovascular, renal and metabolic
Transforming how the world tackles cardiovascular disease and delivering new treatments for people with chronic kidney diseases.
Oncology (Solid Tumors and Hematology)
Combining the power of science and empathy to unravel the inner workings of cancer and develop innovative therapies that restore hope to those with cancer and their loved ones.
Neuroscience, retina and transplant
Committed to change the course of disease progression in neuroscience, retina and transplant.
Spinal Muscular Atrophy (Gene Therapy)
Gene therapies modify part of a patient’s genetic makeup to help treat genetic or inherited diseases. Cell therapies treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body.
Novartis Corporate Center India
Novartis Corporate Centers (NOCCs) are key enablers of Novartis' priorities. We are positioned globally to bring together expert capabilities and talent across functions, to continuously support driving innovation and deliver excellence. The India site is the largest amongst the six centers we have globally and is supporting our purpose of reimagining medicine. This center houses:
Development Hub in India
India serves as an important hub for Development, supporting various stages of development of medicines researched globally by Novartis. This center supports all the global development functions including Global Clinical Operations, Technical R&D, Patient Safety and Pharmacovigilance, Regulatory Affairs, Analytics and Clinical Development.
Biomedical Research
Globally, this division is a network of scientists, physicians, and business professionals using science and innovation to propel the discovery of high-value, next-generation medicines for patients. In India, we are committed to strengthening our existing capabilities to accelerate and support the global vision.
Operations
The capability center provides high-quality support service across multiple functions and capabilities to our sites across the world. These include Business Services, Data, Digital & IT, Manufacturing Supply, Quality, Procurement & Real Estate, Human Resources, Finance, Risk & Compliance, Legal, Communications amongst others.
Creating Value in India
~9 mn
Patients reached in India
~8,300
Total employees in India
Returning to Society
We are committed to championing sustainable livelihoods and empowering communities. Our focus areas are non-communicable diseases, eliminating leprosy and water neutrality. Through our initiatives in 2023, we have directly impacted:
100,000